Cargando…
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791590/ https://www.ncbi.nlm.nih.gov/pubmed/34753179 http://dx.doi.org/10.1182/bloodadvances.2021006006 |
| _version_ | 1784640216770805760 |
|---|---|
| author | Guglielmelli, Paola Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Maccari, Chiara Mora, Barbara Rumi, Elisa Triguero, Ana Finazzi, Maria Chiara Pettersson, Helna Paoli, Chiara Mannelli, Francesco Vanni, Daniele Rambaldi, Alessandro Passamonti, Francesco Alvarez-Larràn, Alberto Andreasson, Bjorn Vannucchi, Alessandro M. Barbui, Tiziano |
| author_facet | Guglielmelli, Paola Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Maccari, Chiara Mora, Barbara Rumi, Elisa Triguero, Ana Finazzi, Maria Chiara Pettersson, Helna Paoli, Chiara Mannelli, Francesco Vanni, Daniele Rambaldi, Alessandro Passamonti, Francesco Alvarez-Larràn, Alberto Andreasson, Bjorn Vannucchi, Alessandro M. Barbui, Tiziano |
| author_sort | Guglielmelli, Paola |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8791590 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87915902022-01-27 Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study Guglielmelli, Paola Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Maccari, Chiara Mora, Barbara Rumi, Elisa Triguero, Ana Finazzi, Maria Chiara Pettersson, Helna Paoli, Chiara Mannelli, Francesco Vanni, Daniele Rambaldi, Alessandro Passamonti, Francesco Alvarez-Larràn, Alberto Andreasson, Bjorn Vannucchi, Alessandro M. Barbui, Tiziano Blood Adv Research Letter American Society of Hematology 2022-01-13 /pmc/articles/PMC8791590/ /pubmed/34753179 http://dx.doi.org/10.1182/bloodadvances.2021006006 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Research Letter Guglielmelli, Paola Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Maccari, Chiara Mora, Barbara Rumi, Elisa Triguero, Ana Finazzi, Maria Chiara Pettersson, Helna Paoli, Chiara Mannelli, Francesco Vanni, Daniele Rambaldi, Alessandro Passamonti, Francesco Alvarez-Larràn, Alberto Andreasson, Bjorn Vannucchi, Alessandro M. Barbui, Tiziano Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title | Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title_full | Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title_fullStr | Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title_full_unstemmed | Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title_short | Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ERNEST Study |
| title_sort | impact of ruxolitinib on survival of patients with myelofibrosis in the real world: update of the ernest study |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791590/ https://www.ncbi.nlm.nih.gov/pubmed/34753179 http://dx.doi.org/10.1182/bloodadvances.2021006006 |
| work_keys_str_mv | AT guglielmellipaola impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT ghirardiarianna impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT carobbioalessandra impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT masciulliarianna impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT maccarichiara impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT morabarbara impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT rumielisa impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT trigueroana impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT finazzimariachiara impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT petterssonhelna impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT paolichiara impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT mannellifrancesco impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT vannidaniele impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT rambaldialessandro impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT passamontifrancesco impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT alvarezlarranalberto impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT andreassonbjorn impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT vannucchialessandrom impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy AT barbuitiziano impactofruxolitinibonsurvivalofpatientswithmyelofibrosisintherealworldupdateoftheerneststudy |